Strategic Point Investment Advisors’s Eli Lilly LLY Stock Holding History

Strategic Point Investment Advisors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$315K	Buy	263 +17	+7%	+$17.4K	0.04%	32
2026 Q1	$226K	Sell	246 -12	-5%	-$12.2K	0.03%	33
2025 Q4	$277K	Buy	+258	New	+$247K	0.04%	32
2025 Q3	–	Sell	-258	Closed	-$201K	–	35
2025 Q2	$201K	Hold	258	–	–	0.03%	34
2025 Q1	$213K	Buy	+258	New	+$215K	0.04%	35
2024 Q4	–	Sell	-258	Closed	-$229K	–	35
2024 Q3	$229K	Hold	258	–	–	0.04%	33
2024 Q2	$234K	Buy	+258	New	+$206K	0.04%	32

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Strategic Point Investment Advisors's LLY Position: Q2 2026 in Review

Strategic Point Investment Advisors increased its Eli Lilly (LLY) stake by 6.9% in Q2 2026, buying an estimated $17.4K and bringing the position to 263 shares worth $315K. The position accounts for 0.04% of the portfolio, ranked #32.

Strategic Point Investment Advisors first reported a position in LLY in Q2 2024 and has held it in 7 quarters since. 2,247 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Strategic Point Investment Advisors held 263 shares of Eli Lilly worth $315K as of Q2 2026.
Strategic Point Investment Advisors bought 17 Eli Lilly shares in Q2 2026, an estimated $17.4K.
Eli Lilly made up 0.04% of Strategic Point Investment Advisors's portfolio in Q2 2026, its #32 holding.
Strategic Point Investment Advisors first reported a position in Eli Lilly in Q2 2024 and has held it in 7 quarters since.
2,247 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Strategic Point Investment Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.